Cigna Group is offering clients a clearer view of how much they pay for drugs through its prescription plans, as the industry responds to rising Washington scrutiny and competition from smaller rivals touting greater transparency.
The insurance giant’s pharmacy-benefit management unit will market a “fully transparent” option charging a flat monthly fee for each member, with more visibility into manufacturers’ prices and discounts. The unit, Express Scripts, will also offer a plan that caps patients’ out-of-pocket costs from $5 to $45 per prescription, depending on the drug.